ritlecitinib will raise the level or effect of fentanyl by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Check Intently. Ritlecitinib inhibits CYP3A4 substrates; coadministration raises AUC and peak plasma concentration delicate substrates, which may increase risk of adverse reactions.Also, fentanyl rapidly crosses the blood